Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTHFD2P5 is a pseudogene that is related in sequence to the gene encoding methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), a mitochondrial enzyme involved in folate-mediated one-carbon metabolism in proliferating cells and cancer. Unlike its functional counterpart, MTHFD2P5 does not produce an active enzyme and is not implicated in any known biological pathway, disease mechanism, or as a drug target. Research and therapeutic interest focus on MTHFD2, not on its pseudogenes such as MTHFD2P5. Therefore, MTHFD2P5 is not considered a target for therapeutic intervention. If your query is about MTHFD2 (not its pseudogene), then that gene is a validated enzyme and emerging cancer drug target. If you intended to query the active enzyme MTHFD2, not the pseudogene, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylenetetrahydrofolate dehydrogenase 2, methenyltetrahydrofolate cyclohydrolase pseudogene 5 (MTHFD2P5).